DEME DEME GROUP NV

Full year results: Outstanding 2024 - strong increases in turnover and profit, positive net cash, unmatched orderbook

Full year results: Outstanding 2024 - strong increases in turnover and profit, positive net cash, unmatched orderbook

Highlights financial year 2024

  • Orderbook stands at 8.2 billion euro at the end of the year, up from 7.6 billion euro a year ago
  • Group turnover grew 25% year-over-year to 4.1 billion euro, with solid growth in all contracting segments
  • EBITDA rose 28% reaching 764 million euro, or 18.6% of turnover, up from 596 million euro, or 18.2% of turnover for 2023
  • Net profit increased by 77%, reaching 288 million euro, compared to 163 million euro a year ago
  • Unprecedented free cash flow generation in 2024, amounting to 729 million euro; resulting in a net cash position of 91 million euro at year-end from a net financial debt of 512 million euro at the end of 2023
  • Proposal for a gross dividend of 3.8 euro per share, compared to 2.1 euro a year ago



Attachment



EN
26/02/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DEME GROUP NV

Guy Sips ... (+11)
  • Guy Sips
  • Jacob Mekhael
  • Kristof Samoy
  • Livio Luyten
  • Lynn Hautekeete
  • Michiel Declercq
  • Thibault Leneeuw
  • Thomas Couvreur
  • Thomas Vranken
  • Wim Hoste
  • Wim Lewi

Dynamic Top Pick List Update June: Removing Merus, Shurgard and Adyen ...

In this June update, we've made four adjustments to the KBC Securities Dynamic Top Pick List: 1.Merus (Removed – 27 May) was removed following the release of strong interim Phase 2 data at the ASCO 2025 conference. Its lead asset, petosemtamab, in combination with Keytruda, showed a 63% overall response rate in first-line treatment of head and neck cancer—significantly outperforming Keytruda monotherapy. The resulting share price surge validated our investment thesis. 2. Adyen (Removed) has de...

 PRESS RELEASE

Annual and Extraordinary General Meeting 2025

Annual and Extraordinary General Meeting 2025 DEME (Euronext: DEME) held its Annual and Extraordinary General Meeting today at the DEME headquarters. Reference is made to the agendas as shared in the convening notice. The shareholders have approved all agenda items of both the Annual and the Extraordinary General Meeting. Attachment

 PRESS RELEASE

Jaarlijkse en Buitengewone Algemene Vergadering

Jaarlijkse en Buitengewone Algemene Vergadering DEME (Euronext: DEME) heeft vandaag zijn Jaarlijkse en Buitengewone Algemene Vergadering gehouden in het hoofdkantoor van DEME. Er wordt verwezen naar de agenda's zoals vermeld in de oproeping. De aandeelhouders hebben alle agendapunten van zowel de Jaarlijkse als de Buitengewone Algemene Vergadering goedgekeurd. Bijlage

ResearchPool Subscriptions

Get the most out of your insights

Get in touch